Alkermes
portfolio management and investment data driven decision making established success criteria and stage gates throughout development process enables kills and risks overall investment cross functional integrated governance to enable strategic decision making extends beyond legal commercial and manufacturing incorporates perspectives into decision making recently discontinued programs program reason for discontinuation phase of development suboptimal pharmaceutical properties phase oncology failure in third party competitive program enabling epigenetic target oncology strategic portfolio fit stress signaling target research proof of concept not achieved preclinical preclinical | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
42 of 144
Related slides by other companies
Synchrony Financial
Investor Day
September 2021
seamless customer experiences through our proprietary products strategic investments and acquisitions in prove clover genesis disc | Synchrony Financial
Pathward Financial
Results
July 2023
investment highlights | Pathward Financial
OG Gallery
Investor Presentation
September 2022
strategic financing plan phase phase | OG Gallery
OpenText
Investor Presentation
April 2020
business system creates strategic value | OpenText
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io